Continuous determination of regional myocardial blood flow with intracoronary Krypton-81m (cas 15678-91-8) in coronary artery disease☆

Add time:09/04/2019    Source:sciencedirect.com

Pacing-induced changes in regional coronary flow were studied continuously with Krypton-81m (cas 15678-91-8) by intracoronary infusion in 25 patients: 21 with 50% or greater diameter narrowing of 1 or more left coronary arteries (group I) and 4 with less than 50% diameter reduction of a left coronary artery (group II). No changes occurred in group II. In group I, krypton-81m perfusion decreased progressively in all areas with more than 70% diameter narrowing, with a simultaneous increase in normal regions. At the end of pacing during angina, krypton-81m perfusion was reduced to 81 ± 4% of control in areas with 71 to 90% diameter reduction (n = 8) and to 69 ± 6% in areas with more than 90% diameter narrowing (n = 15). In contrast, in regions with 50 to 70% diameter reduction changes were variable (decrease in 4 regions, increase in 2 and an unchanged distribution in 1 region). Krypton-81m perfusion decreased early, before general signs of ischemia in areas with more than 90% diameter reduction, whereas this decrease occurred later in regions with 71 to 90% diameter narrowing, concurrently with ST-segment changes but before anginal pain. Although all signs of ischemia had dis-appeared between 2 and 5 minutes after pacing, changes in krypton-81m distribution persisted in most areas for 5 to 15 minutes after pacing. It is concluded that the functional significance of coronary arterial narrowing can be assessed with a continuous intracoronary infusion of krypton-81m. Changes in regional distribution persisted after cessation of pacing-induced ischemia, indicating an ongoing decrease in regional myocardial blood flow.

We also recommend Trading Suppliers and Manufacturers of Krypton-81m (cas 15678-91-8). Pls Click Website Link as below: cas 15678-91-8 suppliers

Prev:Original investigationCoregistered Ventilation and Perfusion SPECT Using Krypton-81m (cas 15678-91-8) and Tc-99m−Labeled Macroaggregated Albumin With Multislice CT: Utility for Prediction of Postoperative Lung Function in Non−Small Cell Lung Cancer Patients
Next:Right ventricular ejection fraction measured by first-pass intravenous Krypton-81m (cas 15678-91-8): Reproducibility and comparison with technetium-99m☆)